Dapiprazole HCl ophthalmic eyedrops have been recently introduced to the optometric profession, and more specifically to optometrists practicing in therapeutic states. This diagonostic drug is used in reversing mydriasis induced by adrenergic or parasympatholytic agents. This is a literature review which covers the entire scope of dapiprazole HCl, or better known as Rev-Eyes, with special emphasis on the specific research studies and the subjective reported side effects, both systemic and ocular.
Files are restricted to Pacific University. Sign in to view.